Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136094 · ClinicalTrials.gov registry record · NA
Suicide in Urban Natives: Detection and Networks to Combat Events
A NA study of Suicide Prevention, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 698
- Enrollment target
- 1
- Study location
NCT03136094: Recruiting NA study of Suicide Prevention, sponsored by University of Colorado, Denver.
NCT03136094 is a NA study of Suicide Prevention that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 698 participants, below the 919-participant average among 21 other Suicide Prevention trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03136094, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 698 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connectedness, and resilience in at-risk youth. The other half will receive usual care that does not include the caring text messages.
Conditions Studied
Interventions
- BEHAVIORAL SBIRT+12
- BEHAVIORAL SBIRT+Usual Care
Study Locations (1)
New Mexico
- First Nations Community HealthSource - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 698 participants |
| Start Date | 2020-03-15 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What NCT03136094 shows while recruiting
NCT03136094 is an interventional study that assigns participants to a tested intervention. The registered 698 participants enrollment target is mid-sized for trials with a published cap, below the 919-participant average among 21 other Suicide Prevention trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 2 interventions - of which SBIRT+12 is the first listed.
NCT03136094 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT03136094 about?
NCT03136094 is a clinical study titled "Suicide in Urban Natives: Detection and Networks to Combat Events". This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connec...
What is the current status of trial NCT03136094?
This trial is currently recruiting. It is a NA study. The enrollment target is 698 participants. The study started on 2020-03-15. Estimated completion is 2025-05-31.
What conditions does trial NCT03136094 study?
This clinical trial studies the following conditions: Suicide Prevention.
What interventions are being tested in trial NCT03136094?
The interventions under investigation include: SBIRT+12 (BEHAVIORAL), SBIRT+Usual Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03136094?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03136094 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03136094's enrollment target sits among peer trials
698 9th of 21 higher than 13 of 21 other Suicide Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Efficacy-Implementation Study for PC CARES in Rural Alaska
RECRUITING · NA
-
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
RECRUITING · NA
-
Suicide Prevention After Community Care Discharge
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04928846 · 698 participants · Phase 3
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- NCT05943535 · 698 participants · Phase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- NCT07187115 · 699 participants · NA
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI